Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNPH1 | O43598 | 1/20 | 0.44 |
| ▸ | NT5E | P21589 | 1/20 | 0.43 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.42 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 7/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19987348 | 0.91 | NT5E (0.47) | NT5E | |
| SCHEMBL19987194 | 0.89 | CYP3A4 (0.43) | DNPH1CYP3A4CYP2C9 | |
| SCHEMBL19987160 | 0.87 | DNPH1 (0.46) | DNPH1NT5EP2RX3P2RX2ADORA3 | |
| SCHEMBL19987349 | 0.87 | CYP3A4 (0.44) | DNPH1NT5EP2RX3P2RX2ADORA3 | |
| SCHEMBL19987204 | 0.86 | NT5E (0.47) | NT5E | |
| SCHEMBL19987270 | 0.85 | NT5E (0.45) | NT5E | |
| SCHEMBL19987299 | 0.84 | CYP3A4 (0.43) | DNPH1CYP3A4CYP2C9 | |
| SCHEMBL19987311 | 0.84 | CYP3A4 (0.46) | DNPH1NT5EP2RX3P2RX2ADORA3 | |
| SCHEMBL19987201 | 0.83 | CYP3A4 (0.42) | NT5EP2RX3P2RX2CYP3A4CYP2C9 | |
| SCHEMBL19987193 | 0.83 | CYP3A4 (0.42) | NT5ECYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018049535-A1 | NUCLEOSIDE ANALOGUES AND METHODS OF USE THEREOF | LCB PHARMA INC. (CA) | 2018-03-22 | — | — | WO | disclosed |